This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

365 results

GSK HK for Healthcare Professional | Homepage

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Shingrix

Herpes zoster vaccine, recombinant, adjuvanted<br> Vaccines

b

a

c

d

Seretide

Salmeterol xinafoate/ fluticasone propionate<br/> Respiratory

Augmentin

Amoxycillin-clavulanate</br> Anti-infectives

Requip

Ropinirole hydrochloride</br> Neurology

Respiratory Overview | COPD

Information for healthcare professionals about COPD, how it impacts patients and treatment goals using an inhaled ICS/LABA combination like Relvar Ellipta (fluticasone furoate/vilanterol).

Resources

Resources for HCPs and patients about SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

Anoro Ellipta

Umeclidinium / vilanterol inhalation powder</br> Respiratory

Dosage and administration

Here you can find dosage and administration of Incruse Ellipta and Relvar Ellipta

Relvar Efficacy

Here you can find efficacy of Relvar

Incruse Efficacy

Here you can find efficacy of Incruse

Adverse Events

Here you can find adverse events of Incruse and Relvar

Incruse Ellipta & Relvar Ellipta

Umeclidinium Inhalation Powder and Fluticasone Furoate / Vilanterol Inhalation Powder</br> Respiratory

Duodart: Indication

generic name<br> Vaccines

Duodart: Dosage and Administration

generic name<br> Vaccines

Bexsero Dosage & Administration

Seretide dosage and administration information to support HK healthcare professionals in increasing knowledge of Bexsero and MenB

Seretide Safety

Seretide safety information for asthma and COPD to support HK healthcare professionals in treating patients

Seretide Patients Resources Kits

Seretide patients kits resources to support HK healthcare professionals in treating patients

COPD

Seretide efficacy information for asthma and COPD and the importance of helping to protect at-risk patients

Asthma

Seretide efficacy information for asthma and COPD and the importance of helping to protect at-risk patients

COPD

Seretide indication information for asthma and COPD, and importance of helping to protect at-risk patients

Asthma

Seretide indication information for asthma and COPD, and importance of helping to protect at-risk patients

Augmentin

Amoxycillin-clavulanate</br> Anti-infectives

Relvar Ellipta

Fluticasone furoate/vilanterol</br> Respiratory

Anoro Ellipta: Scientific Data – Vs Spiolto

Here you can find scientific data of Anoro Ellipta’s efficacy

vs Intermittent

Information that Avamys long-term shows a typical INCS AE profile in adult and adolescent patients and no evidence of systemic corticosteroid exposure.

AR in children

A comprehensive source of information on allergic rhinitis in children, treatment guidelines and safety and tolerability profile of Avamys in children.

Trelegy

Fluticasone furoate/ Umeclidinium/Vilanterol<br/>Respiratory

Trelegy Ellipta Patient Overview-copy

Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol) patient information including how to identify appropriate patients and the importance of reducing exacerbations for COPD patients

Molecules & Device

It shows the benefits of proactive use of Trelegy for COPD patients who are at exacerbation risk

HRQoL

It shows the benefits of proactive use of Trelegy for COPD patients who are at exacerbation risk

Safety

It shows the benefits of proactive use of Trelegy for COPD patients who are at exacerbation risk

Lung Function

It shows the benefits of proactive use of Trelegy for COPD patients who are at exacerbation risk

Exacerbation reduction

It shows the benefits of proactive use of Trelegy for COPD patients who are at exacerbation risk

Duodart: DuoTube

generic name<br> Vaccines

Duodart: Efficacy and Safety

generic name<br> Vaccines

Trelegy

It shows the benefits of proactive use of Trelegy for COPD patients who are at exacerbation risk

Avamys x McDull Promotion

Avamys x McDull Animation

vs MFNS

A page detailing Avamys efficacy vs MFNS. Avamys has preferable sensory attributes compared to MFNS.

Overview

fluticasone furoate<br>Respiratory

vs Bud Spain and Brazil

A page comparing Avamys vs Budesonide, showing that Avamys has a higher receptor affinity and lower bioavailability than budesonide.

AR + asthma

Information on allergic rhinitis and asthma and revealing that Avamys provides a 24-hour effective relief for nasal and ocular AR symptoms.

vs AH/INCS

A comparative page showing Avamys’ efficacy vs AH/INCS on symptom control and quality of life outcomes.

Targeted action

Information on the targeted action of Avamys, high receptor affinity, tissue retention, pharmacodynamic profile and bioavailability

Resources

A comprehensive source of Video resources on allergic rhinitis.

Avamys

Fluticasone furoate</br> Allergy

Safety

Information on the safety and tolerability of Avamys in adults and children.

Maternal immunization offers passive immunity to the newborn via transplacental transfer of maternal antibodies

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

Boostrix Safety & Effectiveness

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

Considerations to evaluate Maternal Immunization

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

Is Maternal Immunization effective?

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

Is Maternal Immunization safe?

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

Optimal timing to vaccinate

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

Your role in prevention

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

Public health burden

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

Communication is key

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

Newborns are at higher risk

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

Why vaccinate with dTap during pregnancy?

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

How to implement Maternal Immunization

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

How does Maternal Immunization Work?

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

Maternal Immunization with Boostrix

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

Maternal Immunization

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

Recommendations

Boostrix is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.

Boostrix

Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis vaccine<br/> Vaccines

Device

A page on Avamys Device’s Efficacy. Avamys is delivered with a once-daily gentle fine mist via a patient-friendly, easy-to-use device.

Guidelines

A summary of how positively Avamys (fluticasone furoate) is regarded in international guidelines

Dosing

A comprehensive source of information on the dosing for Avamys.

Support for patients

Support for your adolescent and adult patients

Nucala

Mepolizumab<br> Asthma

COPD Symposium Asia Pacific Experts Connection (APEC) Webinar

COPD Symposium Asia Pacific Experts Connection (APEC) Webinar help HCPs from other countries to share their research and experience for COPD management

Invasive Meningococcal Disease (IMD) HK

Information on Bexsero for recurrent meningitis

Real-World Evidence (RWE)

Information on Bexsero for recurrent meningitis

Safety

Information on Bexsero for recurrent meningitis

Dosing & Admin

Information on Bexsero for recurrent meningitis

Landing Page

Information on Bexsero for recurrent meningitis

Latest COPD guidelines

Latest major COPD guidelines, GOLD, recommendations for symptomatic patients with COPD

Duodart

Dutasteride tamsulosin hydrochloride</br> Urology

Requip

ropinirole hydrochloride</br> Neurology

Rotarix

Rotavirus Vaccine, Live, Oral Suspension</br> Vaccines

Seretide (fluticasone propionate/ salmeterol xinafoate)

Seretide product information and resources to support HK healthcare professionals

Vaccine Overview

GSK UK information about our vaccines portfolio, as well as resources and latest news.

App

GSK HK App for HCPs to access GSK’s product information, news and order placing

Unmet Need

Patients ≥50 years old are at risk for shingles, no matter how healthy they may feel

Patient Profiles

Is SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) right for your patients? Nearly everyone ≥50 years old needs shingles protection

Safety

The safety of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) was extensively studied in 2 large phase 3 clinical trials

SHINGRIX in your Practice

Read about SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) dosing and administration details, information to share with patients, and guidance for series completion

Efficacy Against Shingles

SHINGRIX delivered >90% efficacy against shingles in all age segments ≥50 years old

PHN and Sustained Efficacy

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) nearly eliminates the risk of developing PHN by preventing shingles

Scientific Rationale

Recommend the shingles vaccine specifically formulated to address age-related decline in immunity

Video Center

Watch on-demand videos about SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

Recommendation

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) is recommended by the CDC for the prevention of shingles (herpes zoster) and related complications for immunocompetent adults aged ≥50 years.

Shingrix

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) product information and resources to support HCPs in their daily practice.

Search Results

GlaxoSmithKline (GSK) UK healthcare professional website search results.

Arexvy Now Approved

Arexvy Now Approved

Arexvy Q&A

Arexvy Q&A

Arexvy Homepage

Arexvy Homepage

Arexvy Vaccine Design

Arexvy Vaccine Design

Arexvy Storage

Arexvy Storage

Arexvy Administration & Vaccine Design

Arexvy Administration & Vaccine Design

Arexvy Safety

Arexvy Safety

Arexvy Efficacy

Arexvy Efficacy & Safety

AREXVY

Vaccines<br> Respiratory Syncytial Virus (Vaccine Recombinant Adjuvanted)

Arexvy Secondary Analyses

Arexvy Secondary Analyses

No results. Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)

show more